Used primarily in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of compounds targeting neurological disorders, including antidepressants and antipsychotics. Its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting drugs. Additionally, it is employed in organic synthesis for creating complex molecules with potential therapeutic applications.